Opinion: Psychedelic therapies are moving from scientific margins toward mainstream biotechnology as researchers search for better treatments for severe psychiatric disorders; The opportunity is significant, but so are the clinical, regulatory and financial risks | Read More in ynet – Culture. in Israel NOWlej.
